Tekmira Pharmaceuticals Corporation Presents Advances In Anti-Viral Product Platform At Scientific Symposium
4/2/2014 9:04:49 AM
VANCOUVER, British Columbia, April 1, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that recent advances in its anti-viral product platform were presented at the 6th International Symposium of Filoviruses, which is taking place in Galveston, Texas from March 30 to April 2, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by